Related Experiment Videos
Caffeine pharmacokinetics in preterm infants older than 2 weeks
S A Pearlman1, C Duran, M A Wood
1Department of Pediatrics, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.
Developmental Pharmacology and Therapeutics
|January 1, 1989
Summary
This study measured caffeine and theophylline metabolite levels in preterm infants. The average half-life for caffeine was approximately 52 hours, and for theophylline, it was about 77 hours.
Area of Science:
- Neonatal Pharmacology
- Pharmacokinetics
- Clinical Chemistry
Background:
- Preterm infants often require respiratory support.
- Caffeine is commonly used to treat apnea of prematurity.
- Understanding drug metabolism in neonates is crucial for safe and effective treatment.
Purpose of the Study:
- To determine the plasma half-life of caffeine and its metabolite, theophylline, in preterm infants.
- To provide pharmacokinetic data for caffeine in a neonatal population.
Main Methods:
- Plasma levels of caffeine and theophylline were measured using high-pressure liquid chromatography.
- Half-life was calculated via computer analysis employing the least-square method.
- Study included 17 preterm infants with a mean gestational age of 29.7 weeks.
Main Results:
- The mean caffeine half-life was 52.03 +/- 23.87 hours.
- The mean theophylline half-life was 77.04 +/- 65.01 hours.
- Infants were studied at a mean postnatal age of 20.7 days.
Conclusions:
- Caffeine exhibits a prolonged half-life in preterm infants.
- Theophylline, a major metabolite, also has an extended half-life in this population.
- These findings are important for optimizing caffeine dosing strategies in neonates.